Infected Fomites Increasing Risk of Coronavirus Transmission during GI Endoscopy

The virus’ stability, characteristics, and modes of transmission through fomites and air droplets make gastrointestinal (GI) endoscopy a high-risk procedure with potential of COVID-19 virus transmission. Such findings are concerning stakeholders in the chromoendoscopy agents market. They are increasing efforts to maintain stable supply chains for products, since healthcare professionals are faced with critical patients in emergency cases.

There is a high risk of COVID-19 transmission through infected fomites such as stethoscope, endoscope, and thermometer. Since both patient and healthcare professionals are at a risk of contracting the novel infection, healthcare systems and companies in the chromoendoscopy agents market are gaining awareness about simple precautionary measures. These include the use of double surgical masks to prevent infection in endoscopy. As such, there is a need for more studies with robust design to ascertain the exact risk of coronavirus transmission during the GI endoscopy.

chromoendoscopy agents market infographic

Request a sample to get extensive insights into the Chromoendoscopy Agents Market

Combination of Dye-based Virtual Chromoendoscopy Improving Medical Outcomes

The chromoendoscopy agents market is projected to expand at a modest CAGR of 3.4% during the forecast period. Dye-based chromoendoscopy is considered the gold standard for accurate detection and characterization of lesions throughout the gastrointestinal tract (GIT). However, the most challenging feature regarding dye-based chromoendoscopy as compared to current virtual chromoendoscopy technique is the longer procedural time. Thus, novel trials are being conducted by researchers, scientists, and biologists. For instance, orally ingested tablets of methylene blue combined with the bowel preparation for screening colposcopy have showed promising results in increasing adenoma detection.

Targeted biopsies of any mucosal abnormalities using dye-based chromoendoscopy, along with a combination of virtual chromoendoscopy with high magnification imaging is increasing medical outcomes.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Good Bowel Preparation, Diagnostic Yield Helps Improve Patient Outcomes

Chromoendoscopy is playing a major role in modern endoscopic imaging. This technique aids the endoscopist in highlighting and characterizing lesions in the GIT. Spraying catheters allow the most controlled and precise application of the dye as a fine mist onto the GIT surface. In colonoscopy, good bowel preparation is critical. This is being achieved using spasmolytic agents such as scopolamine or glucagon, which can be used to avoid bowel peristalsis and an uneven distribution of the dye in some cases.

Companies in the chromoendoscopy agents market are competing to demonstrate good diagnostic yield in the evaluation of dysplastic lesions in Barrett’s oesophagus (BO) and oesophageal adenocarcinoma by enabling targeted biopsies of suspicious areas. Companies in the chromoendoscopy agents market are increasing focus on methylene blue staining to assess areas of BO.

Optical Chromoendoscopy, Technological Developments in Phytodynamic Therapy Boosting Market Growth

Chromoendoscopy is emerging as an alternative to fluorescence spectroscopy, fluorescence endoscopy, and optical coherence tomography. This is evident since companies in the chromoendoscopy agents market are increasing the availability of equipment needed in chromoendoscopy. The interest in chromoendoscopy is being heightened with the development of technologies such as endoscopic mucosal resection and phytodynamic therapy that require precise visual tissue characterization.

Chromoendoscopy is being used in conjunction with developments in endoscopic imaging such as confocal endomicroscopy, confocal endocytoscopy, and magnification endoscopy. Companies in the chromoendoscopy agents market are benefitting from these findings, as these techniques are simple, quick, inexpensive, and safe. On the other hand, acetic acid is being used in the detection of dysplasia within a region of the BO. Companies in the chromoendoscopy agents market are increasing their R&D in optical chromoendoscopy, which is a method that involves digital image processing performed by an endoscope and can produce nearly comparable results to spray chromoendoscopy.

Effective Diagnosis of Colorectal Cancer Triggers Demand for Dye-based Chromoendoscopy

Colonoscopy is being associated with decline in colorectal cancer risk and mortality with the help of detection and resection of precursor lesions. However, its role for preventing the colorectal cancer still has limitations. Companies in the chromoendoscopy agents market are capitalizing on this opportunity to deploy image enhancement techniques to improve the diagnostic yield of colonoscopy and optimize the management of colorectal lesions.

Colonoscopy is one of the most effective diagnostic and therapeutic tools for the prevention of colorectal cancer by detection and removal of precursor lesions. Companies in the chromoendoscopy agents market are increasing the availability of dye-based chromoendoscopy to help oncologists advance in diagnosis of colorectal cancer.

Healthcare Companies Adapting to Shift from Chromoendoscopy to VCE

The virtual chromoendoscopy (VCE) is gaining popularity in the chromoendoscopy agents market to augment the spatial variance of light absorption and scattering properties of tissue in diagnostic and therapeutic applications. It has been found that VCE is emerging as an alternative to conventional chromoendoscopy where the stain agents are necessary. Such findings are influencing the growth of the chromoendoscopy agents market. VCE is capable of detecting spatial variations in light adsorption and scattering of target tissue, which helps in distinguishing abnormal and healthy tissue.

Introduction and adoption of virtual or electronic chromoendoscopy have made dye-based chromoendoscopy less relevant in the day-to-day clinical practice. Healthcare companies are increasing efforts to adapt to such changes in the market landscape. Virtual chromoendoscopy is found to be technically less cumbersome, easy in implementation, and saves time. VCE has become a recurring trend in the market, since the method involves image processing to enhance the vascular pattern of the mucosa. Nevertheless, chromoendoscopy still plays a major role in several conditions.

Contrast Agents Gaining Relevancy in Colon Chromoendoscopy

For the detection of colorectal lesions, two main substances usually indigo carmine, a contrast agent, and methylene blue, an absorptive agent, are used. Manufacturers are increasing their production capabilities in absorptive agents and contract agents to improve clinical numbers, owing to colorectal cancer. As such, crystal violet is used along with the magnification of characterization of lesions in which sub-mucosal invasion (SMI) is suspected.

Before the drop-wise instillation of crystal violet, a mucolytic agent should always be applied onto the lesion to avoid false images of invasive pattern in areas where the dye is not absorbed. Indigo carmine, a contrast agent is gaining relevancy in colon chromoendoscopy and targeted chromoendoscopy. Absorbents, such as methylene blue are being used for the pan-colonic chromoendoscopy.

chromoendoscopy agents market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Chromoendoscopy Agents Market

Analysts’ Viewpoint

Several guidelines and recommendations for prevention of the COVID-19 transmission during endoscopy procedures are being followed by healthcare professionals. The chromoendoscopy agents market is expected to reach US$ 181.2 Mn by 2031. However, the interpretation of findings is not always straightforward, and the impact of chromoendoscopy on clinical outcomes with context to standard endoscopic and histologic methods lacks evidence. Hence, companies should increase awareness about the combination of dye-based and virtual chromoendoscopy with high magnification imaging and increase large controlled trials in the same to improve patient outcomes. The VCE uses narrow band imaging to provide enhanced version of the vascular pattern of the mucosa.

Chromoendoscopy Agents Market: Overview

  • This report analyzes the current scenario and future prospects of the global chromoendoscopy agents market. Rise in prevalence of gastrointestinal diseases, technological advancements in imaging techniques, surge in awareness among people about preventive measures of cancer, and increase in the number of endoscopy procedures are factors projected to propel the global market during the forecast period.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global chromoendoscopy agents market. It also provides information and data analysis of the chromoendoscopy agents market about segments based on product type, application, and end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global chromoendoscopy agents market
  • The report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the global chromoendoscopy agents market
  • The report on the chromoendoscopy agents market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global chromoendoscopy agents market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global chromoendoscopy agents market.

Chromoendoscopy Agents Market: Key Segments

  • In terms of product type, the global chromoendoscopy agents market has been classified into absorptive agents, contrast agents, and reactive agents. The absorptive agents segment is projected to account for major share of the market during the forecast period. Absorptive agents improve the recognition of minute changes in the surface pattern by enhancing the contrast of raised and deepened area. This facilitates the visualization and detection of dysplastic and malignant lesions in the gastrointestinal tract.
  • Based on application, the global chromoendoscopy agents market has been categorized into esophageal, gastric, and colorectal. The colorectal segment dominated the market in 2020. This can be attributed to increase in cases of colorectal cancer and rise in preventive measures for colorectal cancer by the governments of developed countries.
  • In terms of end user, the global chromoendoscopy agents market has been divided into hospitals, ambulatory surgery centers, specialty clinics, diagnostic centers, and others. The hospitals segment is projected to account for major share of the market. Large share of the segment can be ascribed to increase in the number of endoscopy procedures performed in hospitals.
  • Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Chromoendoscopy Agents Market: Regional Outlook

  • In terms of region, the global chromoendoscopy agents market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, Spain, Italy, France, Switzerland, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The chromoendoscopy agents market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The chromoendoscopy agents market study also covers the competitive scenario in these regions.

Companies Covered in Chromoendoscopy Agents Market Report

  • Key players in the global chromoendoscopy agents market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the chromoendoscopy agents market report are
    • Cosmo Pharmaceuticals NV.
    • Merck KGaA
    • Thermo Fisher Scientific
    • Provepharm Life Solutions
    • Enzo Life Sciences, Inc.
    • American Regent, Inc.
    • Micro-Tech Endoscopy
    • Cerba Research
    • Sisco Research Laboratories Pvt. Ltd.
    • LobaChemie Pvt. Ltd.
    • among others

Chromoendoscopy Agents Market – Segmentation

Product Type
  • Absorptive Agents
  • Contrast Agents
  • Reactive Agents
Application
  • Esophageal
  • Gastric
  • Colorectal
End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Diagnostic Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global chromoendoscopy agents market was worth US$ 100 Mn and is projected to reach a value of US$ 200 Mn by the end of 2031

Chromoendoscopy agents market is anticipated to grow at a CAGR of 4% during the forecast period

North America accounted for a major share of the global chromoendoscopy agents market

Chromoendoscopy agents market is driven by increase in incidence of gastrointestinal diseases is a major factor expected to drive the global market during the forecast period

Key players in the global chromoendoscopy agents market include Cosmo Pharmaceuticals NV., Merck KGaA, Thermo Fisher Scientific, Provepharm Life Solutions, Enzo Life Sciences, Inc., American Regent, Inc., Micro-Tech Endoscopy, Cerba Research, Sisco Research Laboratories Pvt. Ltd., and LobaChemie Pvt. Ltd.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chromoendoscopy Agents Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Chromoendoscopy Agents Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.2. Top 3 players operating in the market space

    5.3. Regulatory Scenario

    5.4. Pricing Analysis

    5.5. Patients Journey Landscape

    5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Chromoendoscopy Agents Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Absorptive Agents

        6.3.2. Contrast Agents

        6.3.3. Reactive Agents

    6.4. Market Attractiveness Analysis, by Product Type 

7. Global Chromoendoscopy Agents Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Colorectal

        7.3.2. Esophageal

        7.3.3. Gastric

    7.4. Market Attractiveness Analysis, by Application 

8. Global Chromoendoscopy Agents Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast By End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgery Centers

        8.3.3. Specialty Clinics

        8.3.4. Diagnostic Centers

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by End-user 

9. Global Chromoendoscopy Agents Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Chromoendoscopy Agents Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2031

        10.2.1. Absorptive Agents

        10.2.2. Contrast Agents

        10.2.3. Reactive Agents

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Colorectal

        10.3.2. Esophageal

        10.3.3. Gastric

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgery Centers

        10.4.3. Specialty Clinics

        10.4.4. Diagnostic Centers

        10.4.5. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Product Type 

        10.6.2. By Application 

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Chromoendoscopy Agents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2031

        11.2.1. Absorptive Agents

        11.2.2. Contrast Agents

        11.2.3. Reactive Agents

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Colorectal

        11.3.2. Esophageal

        11.3.3. Gastric

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgery Centers

        11.4.3. Specialty Clinics

        11.4.4. Diagnostic Centers

        11.4.5. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Russia

        11.5.7. Switzerland

        11.5.8. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Product Type 

        11.6.2. By Application 

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Chromoendoscopy Agents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2031

        12.2.1. Absorptive Agents

        12.2.2. Contrast Agents

        12.2.3. Reactive Agents

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Colorectal

        12.3.2. Esophageal

        12.3.3. Gastric

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgery Centers

        12.4.3. Specialty Clinics

        12.4.4. Diagnostic Centers

        12.4.5. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Product Type 

        12.6.2. By Application 

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Chromoendoscopy Agents Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2031

        13.2.1. Absorptive Agents

        13.2.2. Contrast Agents

        13.2.3. Reactive Agents

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Colorectal

        13.3.2. Esophageal

        13.3.3. Gastric

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgery Centers

        13.4.3. Specialty Clinics

        13.4.4. Diagnostic Centers

        13.4.5. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Product Type 

        13.6.2. By Application 

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Chromoendoscopy Agents Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2031

        14.2.1. Absorptive Agents

        14.2.2. Contrast Agents

        14.2.3. Reactive Agents

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Colorectal

        14.3.2. Esophageal

        14.3.3. Gastric

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgery Centers

        14.4.3. Specialty Clinics

        14.4.4. Diagnostic Centers

        14.4.5. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Product Type 

        14.6.2. By Application 

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Company Profiles

        15.1.1. Cosmo Pharmaceuticals NV

            15.1.1.1. Company Overview

            15.1.1.2. Company Financials

            15.1.1.3. Growth Strategies

            15.1.1.4. SWOT Analysis

        15.1.2. Provepharm Life Solutions

            15.1.2.1. Company Overview

            15.1.2.2. Company Financials

            15.1.2.3. Growth Strategies

            15.1.2.4. SWOT Analysis

        15.1.3. Enzo Life Sciences

            15.1.3.1. Company Overview

            15.1.3.2. Company Financials

            15.1.3.3. Growth Strategies

            15.1.3.4. SWOT Analysis

        15.1.4. Sisco Research Laboratories Pvt. Ltd.

            15.1.4.1. Company Overview

            15.1.4.2. Company Financials

            15.1.4.3. Growth Strategies

            15.1.4.4. SWOT Analysis

        15.1.5. Thermo Fisher Scientific

            15.1.5.1. Company Overview

            15.1.5.2. Company Financials

            15.1.5.3. Growth Strategies

            15.1.5.4. SWOT Analysis

        15.1.6. LobaChemie Pvt. Ltd.

            15.1.6.1. Company Overview

            15.1.6.2. Company Financials

            15.1.6.3. Growth Strategies

            15.1.6.4. SWOT Analysis

        15.1.7. Merck KGaA

            15.1.7.1. Company Overview

            15.1.7.2. Company Financials

            15.1.7.3. Growth Strategies

            15.1.7.4. SWOT Analysis

        15.1.8. Cerba Research

            15.1.8.1. Company Overview

            15.1.8.2. Company Financials

            15.1.8.3. Growth Strategies

            15.1.8.4. SWOT Analysis

        15.1.9. American Regent, Inc.

            15.1.9.1. Company Overview

            15.1.9.2. Company Financials

            15.1.9.3. Growth Strategies

            15.1.9.4. SWOT Analysis

        15.1.10. Micro-Tech Endoscopy

            15.1.10.1. Company Overview

            15.1.10.2. Company Financials

            15.1.10.3. Growth Strategies

            15.1.10.4. SWOT Analysis

List of Tables

Table 01: Staining agents for chromoendoscopy

Table 02: Cost associated with Chromoendoscopy Diagnostic Procedure

Table 03: Chromoendoscopy Product Specifications

Table 04: Spray catheters for chromoendoscopy

Table 05: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031

Table 06: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by Application, 2017–2031

Table 07: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: Global Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 23: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figure

Figure 01: Global Chromoendoscopy Agents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 02: Global Chromoendoscopy Agents Market Value Share, by Region, 2020

Figure 03: Global Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 04: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Absorptive Agents , 2017–2031

Figure 05: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Cardiology, 2017–2031

Figure 06: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Neurology, 2017–2031

Figure 07: Global Chromoendoscopy Agents Market Attractive Analysis, by Product Type, (2021–2031)

Figure 08: Global Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 09: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Colorectal, 2017–2031

Figure 10: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Esophageal, 2017–2031

Figure 11: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Gastric, 2017–2031

Figure 12: Global Chromoendoscopy Agents Market Attractive Analysis, by Application, (2021–2031)

Figure 13: Global Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 14: Global Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 15: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 16: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017–2031

Figure 17: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Specialty Clinics, 2017–2031

Figure 18: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 19: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Others, 2017–2031

Figure 20: Global Chromoendoscopy Agents Market Attractive Analysis, by End-user, (2021–2031)

Figure 21: Global Chromoendoscopy Agents Market Value Share Analysis, by Region, 2020 and 2031

Figure 22: Global Chromoendoscopy Agents Market Attractiveness Analysis, by Region, 2021–2031

Figure 23: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

Figure 24: North America Chromoendoscopy Agents Market Value Share Analysis, by Country, 2020 and 2031

Figure 25: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Country, 2021–2031

Figure 26: North America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 27: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 28: North America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 29: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 30: North America Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 31: North America Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 32: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

Figure 33: Europe Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 34: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 35: Europe Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 36: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 37: Europe Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 38: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 39: Europe Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 40: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 41: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

Figure 42: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 43: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 44: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 45: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 46: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 47: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 48: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

Figure 51: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 52: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 53: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 54: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 55: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 56: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 57: Latin America Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 58: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 59: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

Figure 60: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 61: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 62: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 63: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 64: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

Figure 65: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

Figure 66: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 67: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 68: Position Analysis, 2020, by Tier and Size of the Company

Figure 69: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 70: Breakdown of Net Sales (%), by Business Segment, 2020

Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 72: Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 73: Breakdown of Net Sales (%), by Geography, 2019

Figure 74: Breakdown of Net Sales (%), by Business Segment, 2019

Figure 75: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 76: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 77: Breakdown of Net Sales (%), by Geography, 2020

Figure 78: Breakdown of Net Sales (%), by Business Segment, 2020

Figure 79: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 81: Breakdown of Net Sales (%), by Geography, 2020

Figure 82: Breakdown of Net Sales (%), by Business Segment, 2020

Figure 83: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Chromoendoscopy Agents Market